DE69905214T2 - Mittel zur Behandlung der Osteoporose - Google Patents

Mittel zur Behandlung der Osteoporose

Info

Publication number
DE69905214T2
DE69905214T2 DE69905214T DE69905214T DE69905214T2 DE 69905214 T2 DE69905214 T2 DE 69905214T2 DE 69905214 T DE69905214 T DE 69905214T DE 69905214 T DE69905214 T DE 69905214T DE 69905214 T2 DE69905214 T2 DE 69905214T2
Authority
DE
Germany
Prior art keywords
osteoporosis
agents
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69905214T
Other languages
English (en)
Other versions
DE69905214D1 (de
Inventor
Chiyo Yoshizane
Shogeyuki Arai
Yasushi Nishizaki
Kurimoto Masashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10316709A external-priority patent/JP2000038343A/ja
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Application granted granted Critical
Publication of DE69905214D1 publication Critical patent/DE69905214D1/de
Publication of DE69905214T2 publication Critical patent/DE69905214T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
DE69905214T 1998-04-22 1999-04-22 Mittel zur Behandlung der Osteoporose Expired - Fee Related DE69905214T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP12665798 1998-04-22
JP15369698 1998-05-20
JP16446898 1998-05-29
JP21437598 1998-07-29
JP10316709A JP2000038343A (ja) 1998-05-20 1998-11-06 抗骨粗鬆症剤
JP31670698 1998-11-06

Publications (2)

Publication Number Publication Date
DE69905214D1 DE69905214D1 (de) 2003-03-13
DE69905214T2 true DE69905214T2 (de) 2003-08-14

Family

ID=27552698

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69905214T Expired - Fee Related DE69905214T2 (de) 1998-04-22 1999-04-22 Mittel zur Behandlung der Osteoporose

Country Status (4)

Country Link
US (1) US6440446B1 (de)
EP (1) EP0955050B1 (de)
KR (1) KR100571243B1 (de)
DE (1) DE69905214T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU783952B2 (en) 2000-02-04 2006-01-05 Unigene Laboratories, Inc. Nasal calcitonin formulations
JP4754066B2 (ja) 2000-12-22 2011-08-24 株式会社林原生物化学研究所 抗関節障害剤
JP4336467B2 (ja) * 2001-10-15 2009-09-30 株式会社林原生物化学研究所 破骨細胞形成抑制因子の産生を調節し得る物質のスクリーニング方法
US20030191193A1 (en) * 2002-04-03 2003-10-09 Jillian Cornish Lactoferrin
US7018713B2 (en) * 2003-04-02 2006-03-28 3M Innovative Properties Company Flexible high-temperature ultrabarrier
US20050053673A1 (en) * 2003-09-05 2005-03-10 Shrirang Netke Composition and method for facilitating bone healing
US7887851B2 (en) * 2004-06-07 2011-02-15 Kao Corporation Aromatase activator
KR100463825B1 (ko) * 2004-07-30 2004-12-30 화성용 에나미네랄a 활성수의 제조방법 및 이를 이용한 골다공증예방 및 개선용 조성물
EP1937298A4 (de) * 2005-10-14 2009-11-11 Auckland Uniservices Ltd Verwendung von lactoferrin-fragmenten und hydrolysaten
WO2013112897A1 (en) 2012-01-27 2013-08-01 The Regents Of The University Of California Stabilization of biomolecules using sugar polymers
JP6837835B2 (ja) 2013-05-07 2021-03-03 バイオ・ブラスト・ファーマ・リミテッドBio Blast Pharma Ltd. トレハロースの非経口投与によるタンパク質凝集ミオパシーおよび神経変性疾患の治療
US9084720B2 (en) 2013-05-07 2015-07-21 BioBlast Pharma Ltd. Compositions and methods for treating oculopharyngeal muscular dystrophy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3633648B2 (ja) 1993-07-20 2005-03-30 株式会社林原生物化学研究所 マルトース・トレハロース変換酵素とその製造方法並びに用途
JP3455633B2 (ja) * 1996-06-28 2003-10-14 味の素ファルマ株式会社 潰瘍性大腸炎の予防又は治療剤

Also Published As

Publication number Publication date
US6440446B1 (en) 2002-08-27
KR19990083377A (ko) 1999-11-25
KR100571243B1 (ko) 2006-04-13
DE69905214D1 (de) 2003-03-13
EP0955050A1 (de) 1999-11-10
EP0955050B1 (de) 2003-02-05

Similar Documents

Publication Publication Date Title
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
ATE240107T1 (de) Neue verbesserte formulierung zur behandlung der osteoporose
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69924750D1 (de) Gerät zur thermischen behandlung von gewebe
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
DE60138129D1 (de) Apparat zur behandlung von zähnen
DE69935345D1 (de) Methoden und zusammensetzungen zur prävention und behandlung der anämie
DE69928542D1 (de) 5ht2-agoniste zur behandlung des glaukoms
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE69918222D1 (de) Intranasale Zubereitungen zur Behandlung sexueller Störungen
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
ATE300597T1 (de) Behandlung von geweben
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69936890D1 (de) Vorrichtung zur Behandlung von Ischämie
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE69905214T2 (de) Mittel zur Behandlung der Osteoporose
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee